Epitope Mapping
In the race to engineer high-affinity, highly selective antibodies, understanding the precise interaction between antibody and antigen is no longer a luxury—it’s a necessity. Epitope mapping using cross-linking mass spectrometry (XL-MS) offers a powerful, high-resolution approach to define these critical interfaces with speed and confidence.
Epitope Mapping
In the race to engineer high-affinity, highly selective antibodies, understanding the precise interaction between antibody and antigen is no longer a luxury—it’s a necessity. Epitope mapping using cross-linking mass spectrometry (XL-MS) offers a powerful, high-resolution approach to define these critical interfaces with speed and confidence.
Why XL-MS for Epitope Mapping?
Traditional epitope mapping methods, such as alanine scanning or peptide arrays, can be labor-intensive, low-throughput, or limited to linear epitopes. XL-MS breaks through these constraints by enabling:
- Structural-level resolution: Capture both linear and conformational epitopes in native-like conditions
- Rapid turnaround: Generate actionable data in days, not weeks
- Minimal sample requirements: Compatible with purified proteins produced in smaller scale transient expressions
- Orthogonal validation: Complements cryo-EM, HDX-MS, or SPR with direct spatial constraints
How It Works
XL-MS leverages bifunctional cross-linkers to covalently tether interacting residues between antibody and antigen. After digestion and LC-MS/MS analysis, cross-linked peptides are identified and mapped onto structural models—pinpointing the epitope and paratope with sub-nanometer precision.
This approach is especially valuable for:
- Characterizing therapeutic antibody candidates
- Comparing epitope coverage across clones or formats
- De-risking IP and biosimilarity assessments
- Guiding rational affinity maturation and humanization
Applications
Whether you're developing monoclonals, bispecifics, or antibody-drug conjugates, XL-MS epitope mapping empowers teams to:
- Make informed platform selections
- Accelerate lead optimization
- Strengthen regulatory packages with structural evidence
Ready to Map What Matters?
Our XL-MS epitope mapping service combines cutting-edge instrumentation, proprietary cross-linking chemistries, and expert bioinformatics to deliver high-confidence results tailored to your program’s needs.
Let’s turn molecular insight into strategic advantage.
Tell us what you’re working on.
Share the useful starting details and your enquiry will be sent securely to Fusion’s scientific team.